We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App




One-Third of Breast Cancer Cases Treated Unnecessarily

By HospiMedica International staff writers
Posted on 26 Jan 2017
Print article
A new study suggests that one in three women with breast cancer detected by a mammogram may be treated unnecessarily.

Researchers at the Nordic Cochrane Centre, the University of Oslo, and the Norwegian Institute of Public Health conducted a cohort study to assess the association between biennial mammography screening and the size of detected tumors in women aged 35 to 84 years, measuring trends in the incidence of advanced (>20 mm) and non-advanced (≤20 mm) breast cancer tumors in both screened and non-screened women.

Two approaches were used to estimate the amount of over-diagnosis. The first compared the incidence of advance and non-advanced tumors among women aged 50-84 years in screening and non-screening areas; the second compared the incidence for non-advanced tumors among women aged 35-49, 50-69, and 70-84 years in screening and non-screening areas. The researchers assumed that if screenings work as intended, the number of small, curable breast tumors should increase, reducing the number of large cancers by about the same amount.

The results revealed that screening was not associated with lower incidence of advanced tumors. The first approach found 271 invasive breast cancer tumors and 179 ductal carcinoma in situ (DCIS) lesions over-diagnosed in 2010, an over-diagnosis rate of 24.4% (including DCIS) and 14.7% (excluding DCIS). The second approach, which accounted for regional differences in women younger than the screening age, found 711 invasive tumors and 180 cases of DCIS over-diagnosed in 2010, an over-diagnosis rate of 48.3% (including DCIS) and 38.6% (excluding DCIS). The study was published on January 10, 2017, in Annals of Internal Medicine.

“Breast cancer screening was not associated with a reduction in the incidence of advanced cancer. It is likely that one in every three invasive tumors and cases of DCIS diagnosed in women offered screening represent over-diagnosis,” concluded study coauthor Karsten Jorgensen, PhD, of the Nordic Cochrane Center, and colleagues. “Although mammograms in Denmark detected a lot more breast cancers, these were mostly small, early-stage tumors. The number of advanced cancers did not fall.”

DCIS is the most common type of non-invasive breast cancer, in which the abnormal cells are contained inside the milk ducts. If DCIS is not treated, it may eventually develop into invasive breast cancer, which can spread outside the ducts into the breast tissue and then possibly to other parts of the body. Since DCIS cannot usually be felt as a breast lump or other breast change, most cases are diagnosed following routine screening with mammograms or ultrasound, appearing as micro-calcifications.

Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Silver Member
Compact 14-Day Uninterrupted Holter ECG
NR-314P
New
Transvaginal Tube
LiNA McCartney Tube

Print article

Channels

Critical Care

view channel
Image: The permeable wearable electronics developed for long-term biosignal monitoring (Photo courtesy of CityUHK)

Super Permeable Wearable Electronics Enable Long-Term Biosignal Monitoring

Wearable electronics have become integral to enhancing health and fitness by offering continuous tracking of physiological signals over extended periods. This monitoring is crucial for understanding an... Read more

Surgical Techniques

view channel
Image: NTT and Olympus have begun the world\'s first joint demonstration experiment of a cloud endoscopy system (Photo courtesy of Olympus)

Cloud Endoscopy System Enables Real-Time Image Processing on the Cloud

Endoscopes, which are flexible tubes inserted into the body's natural openings for internal examination and biopsy collection, are becoming increasingly vital in medical diagnostics. Their minimal invasiveness... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The PATHFAST hs-cTnI-II high-sensitivity troponin assay has been developed for the PATHFAST Biomarker Analyzer (Photo courtesy of Polymedco)

POC Myocardial Infarction Test Delivers Results in 17 Minutes

Chest pain is the second leading cause of emergency department (ED) visits by adults in the United States, generating over 7 million visits annually. In the event of a suspected heart attack, physicians... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.